TransCode shareholders approve warrant adjustments and share issuance at special meeting

Transcode Therapeutics, Inc.

Proposal One approved: full issuance of shares upon exercise of Series C and D warrants with floor price of $2.4882.
Proposal Two approved: adjournment if needed to solicit more votes; not used as Proposal One passed.
Vote on Proposal One: 130,226 for, 51,288 against, 8,722 abstained; 190,236 shares present (quorum).
Total shares entitled to vote: 523,261; no broker non-votes on either proposal.

item 5.07 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-016947
form_type: 8-K
ticker: RNAZ
cik: 0001829635
company_name: Transcode Therapeutics, Inc.
filed_at: 2025-02-25T23:59:59+00:00
discovered_at: 2026-05-14T18:03:05.132734+00:00
generated_at: 2026-05-26T04:56:32.021605+00:00
sec_items: ["5.07", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-016947
json_url: https://secwatch.observer/filing/0001104659-25-016947.json
markdown_url: https://secwatch.observer/filing/0001104659-25-016947.md
text_url: https://secwatch.observer/filing/0001104659-25-016947.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1829635/000110465925016947/0001104659-25-016947-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1829635/000110465925016947/tm257516d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

GIPR

Generation Income Properties prices $5.0M public offering of 23.8M shares and warrants at $0.21/unit

GENERATION INCOME PROPERTIES, INC. June 1, 2026, 5:27 PM ET other_material Items 1.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

MUX

McEwen receives $49.4M dividend from Minera Santa Cruz; total 2026 dividends now $58.2M

McEwen Inc. June 1, 2026, 5:14 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CRM

Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected

Salesforce, Inc. June 1, 2026, 4:43 PM ET other_material Items 5.07, 5.02, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

EMYB

Embassy Bancorp expands stock repurchase program by additional $5M

Embassy Bancorp, Inc. June 1, 2026, 4:37 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BRANDYWINE OPERATING PARTNERSHIP, L.P.

Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP

BRANDYWINE OPERATING PARTNERSHIP, L.P. June 1, 2026, 4:30 PM ET other_material Items 1.01, 2.03, 5.02, 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CTXR

Citius Oncology reports Phase 1 combo data: 24% ORR, 33% in endometrial cancer; Phase 2 planned

Citius Pharmaceuticals, Inc. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CTOR

Citius Oncology reports Phase 1 combo data for LYMPHIR in gynecologic cancers; 24% ORR, 33% in endometrial cancer

CITIUS ONCOLOGY, INC. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

SIRI

Sirius XM shareholders approve 7.2M share increase in 2024 equity plan, elect directors

SIRIUS XM HOLDINGS INC. June 1, 2026, 4:28 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001104659-25-016947

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.